VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DNLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DNLIDenali Therapeutics Inc.
$26.31$4.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDNLIPrice History

DNLI logoDenali Therapeutics Inc. (DNLI) Stock Price History

Historical prices from 2017 to 2026

$26.31+0.57  (+2.21%)close Jul 7
Returns
1M
+34.6%
3M
+35.5%
YTD
+61.7%
1Y
+84.6%
3Y
-3.5%
5Y
-19.2%
ATH$93.94Dec 2020-72.0%
ATL$10.57Apr 2025pre-split
Avg Vol (50D)1.7M/ day
52-Week Range$12.58 — $26.80
LowCurrent: $26.31High

Loading 10-year price history...

DNLI Historical Performance

1 YearTotal Return
+84.6%
Price: +84.6%
3 YearsTotal Return
-10.1%
CAGR: -3.5%
Price: -10.1%
5 YearsTotal Return
-65.5%
CAGR: -19.2%
Price: -65.5%
YTD
+61.7%

DNLI Annual Returns

Year-by-year price performance · 2017–2026

Best+411.0%2020
Worst-41.2%2022
Up years3/10
2017-27.1%
2018+28.1%
2019-9.9%
2020+411.0%
2021-37.1%
2022-41.2%
2023-22.3%
2024-4.7%
2025-20.8%
2026+30.2%
2017 annual price return
-27.1%
2018 annual price return
+28.1%
2019 annual price return
-9.9%
2020 annual price return
+411.0%
2021 annual price return
-37.1%
2022 annual price return
-41.2%
2023 annual price return
-22.3%
2024 annual price return
-4.7%
2025 annual price return
-20.8%
2026 annual price return
+30.2%
LessMore
Alpha vs S&P 500
1Y+51.5%
3Y-24.4%
5Y-30.5%

Price returns only.

Download Historical Data

2,154 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

DNLI Stock Price Trajectory (2017–2026)

As of July 8, 2026, Denali Therapeutics Inc. (DNLI) trades at $26.31, representing a +84.6% return over the past year. The stock has delivered a -65.5% total return over five years (-19.2% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $93.94 on December 22, 2020. From this peak, DNLI has corrected -72.0%, currently trading 39% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers PRAX (+594.0% 1Y), ARVN (+10.3% 1Y), and RCUS (+268.0% 1Y), DNLI has underperformed the peer group average. Compare DNLI vs PRAX →

DNLI Historical Price Data · from 2017

Rows 1–50 of 2,154
Date Open High Low Close Volume Change %
2026-07-0726.0226.7625.3626.311.41M+2.21%
2026-07-0625.9826.0725.0425.741.28M-0.35%
2026-07-0226.1726.8025.4325.831.50M-0.58%
2026-07-0125.7226.1825.6125.981.17M+1.01%
2026-06-3026.0026.3625.6325.721.92M-0.66%
2026-06-2925.5426.1125.5425.892.13M+1.25%
2026-06-2624.7825.7024.6725.570+3.40%
2026-06-2524.8325.9624.6624.731.09M-0.36%
2026-06-2425.0925.6924.7124.821.12M+0.20%
2026-06-2324.2725.2923.5124.771.57M+2.99%
2026-06-2223.8024.3423.6424.051.53M+3.17%
2026-06-1824.1624.6523.2123.312.18M-0.77%
2026-06-1722.2824.2022.0923.492.54M+7.11%
2026-06-1622.1222.4721.6821.931.41M-1.31%
2026-06-1521.8622.4421.4122.221.25M+2.59%
2026-06-1221.0222.1520.9221.662.17M+3.04%
2026-06-1120.7821.6820.3721.021.92M+1.99%
2026-06-1020.4521.7120.1620.612.40M-0.87%
2026-06-0919.8420.9219.4520.791.86M+6.40%
2026-06-0819.8520.0519.1919.541.87M+0.10%
2026-06-0519.8919.9419.2419.522.15M-3.08%
2026-06-0419.7021.1019.6720.141.82M+2.44%
2026-06-0319.3419.6919.1919.661.01M+1.60%
2026-06-0219.9620.0618.9219.351.64M-5.19%
2026-06-0120.8620.8620.0320.411.50M-2.99%
2026-05-2920.8421.1820.8421.041.54M+0.43%
2026-05-2820.1021.0519.6620.951.31M+3.66%
2026-05-2719.6220.3419.5720.211.26M+4.28%
2026-05-2618.8619.6318.6019.382.10M+3.97%
2026-05-2218.5219.0618.1818.643.38M-3.42%
2026-05-2118.5519.3318.3519.301.18M+2.50%
2026-05-2018.2119.1818.1118.831.32M+3.98%
2026-05-1917.9618.4017.7118.112.10M-1.58%
2026-05-1818.6319.1118.2318.401.66M-1.18%
2026-05-1519.0119.3718.5018.622.13M-3.97%
2026-05-1419.9720.0018.9119.391.79M-2.07%
2026-05-1319.4519.9519.2919.801.13M+1.75%
2026-05-1219.7619.9719.1819.461.74M-1.07%
2026-05-1119.6920.5519.4319.671.71M+0.25%
2026-05-0819.4420.5319.4419.621.90M-0.46%
2026-05-0720.2520.4119.1919.711.21M-3.38%
2026-05-0619.2020.4918.9120.402.18M+7.82%
2026-05-0519.1519.4018.3318.92810K+1.34%
2026-05-0418.1419.1418.1018.672.41M+2.02%
2026-05-0118.7018.8118.2318.301.42M-2.24%
2026-04-3018.7318.9218.3518.722.44M+0.65%
2026-04-2919.6020.1718.2318.602.95M-7.28%
2026-04-2819.9720.4319.8420.061000K+0.60%
2026-04-2719.7620.3619.7619.94968K+0.35%
2026-04-2420.0520.0519.2719.871.00M+2.16%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DNLI — Frequently Asked Questions

Quick answers to the most common questions about buying DNLI stock.

How has DNLI stock performed recently?

DNLI returned +84.6% over the past year, beating its 5-year annualized CAGR of -19.2%. The stock trades above its 200-day moving average, confirming the uptrend.

What is DNLI's all-time high price?

Denali Therapeutics Inc. reached $93.94 on 2020-12-22. The 52-week high is $26.80. Current 1-year return of +84.6% places the stock closer to historical peaks.

Where can I download DNLI historical price data?

This page provides DNLI daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2017-2026, downloadable in CSV format.

432 data points · sampled from 2,154